It is uncertain whether dietary intake of mushrooms rich in dietary fibre and several antioxidants is associated with a lower risk of dementia. We sought to examine prospectively the association between mushroom intake and the risk of disabling dementia. We performed a prospective study involving 3750 people aged 40 to 64 years residing in three communities who participated in an annual cardiovascular risk survey from 1985 to 1999. Cases of incident disabling dementia were surveyed from 1999 to 2020. We calculated the hazard ratios (HR) and 95 % CI for incident total dementia according to mushroom intake among participants with or without a history of stroke. During a mean 16·0 years’ follow-up in 3739 eligible participants, 670 people developed disabling dementia. For women, mushroom intake was inversely associated with the risk of total dementia and the association was confined to dementia without a history of stroke. The multivariable HR (95 % CI) for total dementia in women were 0·81 (0·62, 1·06) for mushroom intake of 0·1–14·9 g/d and 0·56 (0·42, 0·75) for mushroom intake above 15·0 g/d (Pfor trend = 0·003) compared with no intake. The corresponding HR (95 % CI) for dementia without a history of stroke were 0·66 (0·47, 0·93) and 0·55 (0·38, 0·79) (Pfor trend = 0·01). In men, no associations were observed between mushroom intake and the risk of disabling dementia. Among Japanese women, dietary mushroom intake was associated with a lower risk of disabling dementia.

A 54-year-old woman prepares dinner around 8:00 pm that includes mushrooms that she picked from her yard. The next morning, around 8:00 am, the woman (patient), her daughter, and son-in-law all develop abdominal cramps, violent vomiting, and diarrhea. They present to the emergency department and are admitted for dehydration and intractable vomiting with a presumed diagnosis of food poisoning. Twenty-four hours later, they appear well with stable vital signs and improved symptoms. Four hours later, 36 hours post-ingestion, the patient becomes lethargic. A venous blood gas reveals pH, 7.1; PCO2, 16 mmHg; and her AST was 3140 units/L with an ALT of 4260 units/L and an INR of 3.7.

A coplanar waveguide-fed planar hexagonal monopole ultra-wideband antenna with dual-band rejection characteristics is proposed in this paper. The desired notch frequencies at 3.5 and 5.5 GHz are realized by incorporating mushroom structures. The input impedance and surface current distributions are used for analysis and explanation of the effects of mushroom cells. The prototype and proposed antennas are fabricated and tested. From the measured results, the proposed antenna provides an operating band of 2.81–14.32 GHz for 2 ≤ voltage standing wave ratio (VSWR), while the dual-band stop function is in the frequency bands of 3.3–3.7 GHz and 5.10–5.88 GHz. Moreover, the antenna model also exhibits constant group delay and linear phase in the pass band. The proposed antenna has appreciable gain and efficiency over the whole operating band except the notch bands.

Mushrooms are the fungi that have been used as food since time immemorial. Nutritionally they are a valuable source of health food, which is low in calories, and rich in carbohydrates, essential amino acids, fibre, important vitamins and minerals. Mushrooms have also been used in medicine for centuries in the Orient but their potential as health potentiators and elicitors of immune system is recent. In the last two decades there has been an upsurge on the use of mushrooms as nutraceuticals and many edible species have been thoroughly investigated and authenticated for medicinal use. The species that have been properly analysed for medicinal value are: Ganoderma lucidum (Reishi), Lentinus edodes (Shiitake), Grifola frondosa (Maitake), Agaricus blazei (Hime-matsutake), Cordyceps militaris (Caterpillar fungus), Pleurotus ostreatus (Oyster mushroom) and Hericium erinaceous (Lions mane). There are many more species of cultivated and wild edible and non-edible mushrooms that have been analysed for both their nutritional and nutraceutical components but to a lesser extent than those listed above. The active constituents found in mushrooms are polysaccharides, dietary fibres, oligosaccharides, triterpenoids, peptides and proteins, alcohols and phenols, and mineral elements such as zinc, copper, iodine, selenium and iron, vitamins, amino acids etc. These have been found to boost the immune system, have anti-cancerous properties, act as anti-hypercholesterolaemic and hepato-protective agents, show anti-HIV activity and anti-viral activity, and ameliorate the toxic effect of chemo- and radiotherapy. Many of the species are known to be aphrodisiacs. Many commercial products from these mushrooms are available in the market. Prominent among these are: Lentinan from Lentinus edodes, Concord Sunchih and Reishi Plus from Ganoderma lucidum, Grifon from Grifola frondosa and Didanosine from Cordyceps militaris. The nutraceuticals have been found to relieve the stress and pressure of modern society by stimulating both basic and secondary immune responses of the immune system. There are more than 5000 species of mushrooms recorded from all over the world out of which around 2000 are identified as edible. A large number of the species are yet to be analysed for their nutraceutical/medicinal potential.

Chinese natural medicinal products as feed supplements have been used as growth and health promoters in farm animals in China for centuries. A current estimation of the number of Chinese natural medicines ranges between 6,000 and 8,000, of which less than 5% has immuno-active properties. Most of these medicinal products originate from plants. Polysaccharides are considered to be the most important components, which may act as immune enhancers or immuno-modulators. The relationship between polysaccharide structure and bio-activity is, however, not well understood. In this review, immune activities of the polysaccharides from two mushrooms, Lentinus edodes and Tremella fuciformis, and a herb, Astragalus membranaceus radix, are reported, based on studies in chickens, mice, rats and humans. It can be concluded from these studies that polysaccharides derived from these products can play important roles in: (1) stimulating the growth of immune organs such as spleen, thymus and bursa; (2) increasing the number and activities of many interdependent cell types such as T, B lymphocytes, macrophages, natural killer (NK) cells and lymphokine-activated killer (LAK) cells; (3) enhancing T-cell mediated immune response, such as an increased rate of T-lymphocyte transformation and proliferation; (4) enhancing humoral immune response, such as spleen and serum antibody production, the number of haemolytic plague forming cells (PFC) and haemolysin production and (5) inducing secretion and production of cytokines and complements of T-cells and NK cells.

Today's poultry producers are confronted by numerous prophylactic techniques to prevent diseases. The immuno-active polysaccharides from mushrooms and herbs might be good candidates as health promoting feed additives in poultry diets. Further studies are needed to investigate the effects of such bioactive components to improve productive performance in chicken and to elucidate the possible modes of action related to the gut ecosystem and the immune response.